Why the Same Dose Does Not Work the Same Way for Everyone

When a physician writes a prescription, the dosage on that slip of paper typically reflects clinical trial data, FDA-approved labeling, and established treatment guidelines. What it does not always reflect is you — your age, your body composition, the current state of your kidneys and liver, or the particular genetic variants you carry that influence how your cells process chemical compounds. The concept of a universal therapeutic dose is, in many ways, a useful fiction. In practice, the same milligram amount of a given drug can produce vastly different effects depending on the individual taking it.

Understanding the factors that shape your personal drug response is not about second-guessing your physician. It is about being an informed participant in your own care — and knowing when a conversation about dosage adjustment is not only appropriate but necessary.

The Body Changes: How Age Reshapes Drug Processing

Age is one of the most significant and consistently underappreciated variables in medication response. The physiological changes that accompany aging affect nearly every system involved in how the body handles drugs — a field known as pharmacokinetics.

In older adults, the kidneys gradually lose filtration efficiency, and liver enzyme activity tends to decline. Since most medications are broken down by the liver and eliminated by the kidneys, reduced function in either organ can cause drugs to accumulate in the body at higher concentrations than intended. What is a standard dose for a 40-year-old may be effectively an overdose in a 75-year-old with diminished renal clearance.

This is not a minor concern. The American Geriatrics Society publishes the Beers Criteria — a regularly updated list of medications considered potentially inappropriate for older adults — precisely because standard dosing assumptions frequently do not apply to this population. Drugs such as certain sleep aids, muscle relaxants, and antianxiety medications carry heightened risks of falls, cognitive impairment, and adverse cardiovascular effects in elderly patients.

In children and adolescents, the challenge runs in the opposite direction. Pediatric dosing is not simply a matter of scaling down an adult dose proportionally. Enzyme systems responsible for drug metabolism mature at different rates, and children's bodies distribute medications differently than adult bodies do. Weight-based dosing is common in pediatric practice, but even that approach has limitations when other developmental factors are at play.

Body Composition: More Than a Number on a Scale

Body weight influences dosing in ways that go beyond simple size. What matters pharmacologically is not just how much a person weighs, but how that weight is distributed between lean muscle mass and adipose (fat) tissue.

Fat-soluble drugs — including certain sedatives, some antidepressants, and a number of anesthetics — distribute into fatty tissue and may have a prolonged or intensified effect in individuals with higher body fat percentages. The drug essentially has more storage space in the body, which can extend its duration of action and delay elimination.

Conversely, some medications are dosed based on lean body weight or ideal body weight rather than total body weight, because the drug does not distribute meaningfully into fat tissue. Administering such a drug based on total weight in a person with obesity could result in an excessive dose.

This is an area where clinical judgment and sometimes individualized dosage calculations are essential — and where patients should feel empowered to ask their prescriber what measurement was used to determine their dose.

Liver and Kidney Function: The Body's Drug-Processing Infrastructure

The liver and kidneys are the primary organs responsible for metabolizing and eliminating most pharmaceutical compounds. When either is compromised — whether by chronic disease, acute illness, or age-related decline — the standard dosage assumptions built into prescribing guidelines may no longer hold.

Hepatic (liver) metabolism involves a family of enzymes, most notably the cytochrome P450 system, that chemically transform drugs into forms the body can eliminate. Conditions such as cirrhosis, hepatitis, or nonalcoholic fatty liver disease can significantly reduce this metabolic capacity, causing drugs to remain in the bloodstream longer and at higher concentrations.

Renal (kidney) clearance is the mechanism by which many drugs and their metabolic byproducts are filtered out of the blood and excreted in urine. Chronic kidney disease, which affects an estimated 37 million Americans according to the National Kidney Foundation, is a particularly common reason for dosage adjustment. Medications such as certain antibiotics, diabetes drugs like metformin, and some heart medications require dose reduction or alternative selection in patients with impaired kidney function.

Routine blood tests — specifically serum creatinine and the calculated glomerular filtration rate (GFR) — give clinicians a reliable picture of kidney function. If you have been diagnosed with any degree of kidney or liver impairment, it is worth confirming with your prescriber that your current medication doses have been reviewed in that context.

Pharmacogenomics: When Your Genes Affect Your Prescription

One of the more rapidly evolving areas of personalized medicine involves pharmacogenomics — the study of how genetic variation influences drug response. Certain inherited differences in liver enzyme genes can make an individual a "poor metabolizer" or an "ultra-rapid metabolizer" of specific drugs.

For example, the enzyme CYP2D6 is responsible for metabolizing a wide range of commonly prescribed medications, including certain antidepressants, pain medications, and beta-blockers. A person who genetically produces very little CYP2D6 activity may accumulate dangerous concentrations of a standard dose, while someone with an unusually active version of the gene may clear the drug so quickly that it provides no therapeutic benefit.

Pharmacokinetic genetic testing is not yet routine for most prescriptions in the United States, but it is increasingly available and is already standard practice in certain specialty areas such as oncology and psychiatry. If you have had unexpected reactions to medications in the past — either an unusual lack of effect or an exaggerated response — discussing pharmacogenomic testing with your physician may be worthwhile.

When to Have the Dosage Conversation

Knowing that these variables exist is valuable. Knowing when to act on that knowledge is equally important. Consider raising the topic of dosage review with your prescriber if:

• You are over the age of 65 and taking multiple medications
• You have been diagnosed with chronic kidney or liver disease
• You have experienced significant weight changes since your prescription was written
• A medication does not seem to be producing the expected effect, or its effects feel disproportionately strong
• You are pregnant or planning to become pregnant, as drug distribution and metabolism change substantially during pregnancy
• You have had unusual or unexplained reactions to medications previously

Bring your complete medication list to these conversations — including over-the-counter products and supplements — since interactions between compounds can further alter how individual drugs behave in your system.

Precision Over Assumption

The standard dose printed on a prescription label represents a starting point informed by population-level data. It is not a guarantee that the amount is precisely right for your body at this moment in your life. Medicine is increasingly moving toward individualized treatment approaches, and patients who understand the biological factors at play are better positioned to participate in that process.

Your pharmacist is also a valuable resource in this conversation. In addition to checking for drug interactions, a clinical pharmacist can flag dosing concerns related to kidney or liver function and advise on whether your current regimen warrants a prescriber review. Taking an active role in these discussions is not overstepping — it is sound health practice.